Concepts (197)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Gynecology | 10 | 2020 | 55 | 2.040 |
Why?
|
| Obstetrics | 10 | 2020 | 46 | 2.040 |
Why?
|
| Infertility | 4 | 2019 | 35 | 1.940 |
Why?
|
| Education, Medical, Undergraduate | 12 | 2022 | 51 | 1.660 |
Why?
|
| Clinical Clerkship | 7 | 2019 | 20 | 1.510 |
Why?
|
| Insemination, Artificial | 3 | 2021 | 23 | 1.480 |
Why?
|
| Pregnancy Rate | 5 | 2023 | 45 | 1.470 |
Why?
|
| Polycystic Ovary Syndrome | 6 | 2021 | 63 | 1.410 |
Why?
|
| Semen | 2 | 2021 | 27 | 1.390 |
Why?
|
| Reproductive Techniques, Assisted | 3 | 2020 | 17 | 1.310 |
Why?
|
| Healthcare Disparities | 2 | 2019 | 78 | 1.190 |
Why?
|
| Fertility | 3 | 2023 | 58 | 1.130 |
Why?
|
| Fertilization in Vitro | 5 | 2023 | 24 | 1.070 |
Why?
|
| Acupuncture Therapy | 2 | 2018 | 5 | 1.070 |
Why?
|
| Pregnancy | 13 | 2023 | 1131 | 1.060 |
Why?
|
| Female | 33 | 2023 | 14463 | 0.900 |
Why?
|
| Abortion, Induced | 1 | 2023 | 16 | 0.860 |
Why?
|
| Curriculum | 6 | 2022 | 262 | 0.790 |
Why?
|
| Population Surveillance | 2 | 2019 | 85 | 0.770 |
Why?
|
| Humans | 40 | 2023 | 26827 | 0.730 |
Why?
|
| Pregnancy Outcome | 2 | 2020 | 128 | 0.710 |
Why?
|
| Infertility, Female | 2 | 2018 | 42 | 0.710 |
Why?
|
| Adult | 19 | 2021 | 7383 | 0.700 |
Why?
|
| Indians, North American | 3 | 2019 | 511 | 0.690 |
Why?
|
| Sphingomyelins | 1 | 2019 | 11 | 0.660 |
Why?
|
| Ovarian Follicle | 4 | 2015 | 84 | 0.650 |
Why?
|
| Spermatozoa | 1 | 2019 | 29 | 0.650 |
Why?
|
| Sex Factors | 2 | 2018 | 446 | 0.640 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2019 | 65 | 0.630 |
Why?
|
| Vitamin D | 2 | 2018 | 44 | 0.620 |
Why?
|
| Vitamin D Deficiency | 1 | 2018 | 27 | 0.600 |
Why?
|
| Health Services Accessibility | 1 | 2019 | 90 | 0.600 |
Why?
|
| Live Birth | 4 | 2021 | 39 | 0.590 |
Why?
|
| Urogenital Abnormalities | 1 | 2017 | 4 | 0.580 |
Why?
|
| Ultrasonography | 5 | 2020 | 228 | 0.580 |
Why?
|
| Uterus | 1 | 2017 | 31 | 0.570 |
Why?
|
| Cervix Uteri | 1 | 2017 | 63 | 0.560 |
Why?
|
| Hysterectomy | 1 | 2017 | 80 | 0.560 |
Why?
|
| United States | 11 | 2023 | 2033 | 0.540 |
Why?
|
| Students, Medical | 6 | 2020 | 95 | 0.530 |
Why?
|
| Embryo Transfer | 2 | 2014 | 13 | 0.490 |
Why?
|
| Ovariectomy | 3 | 2013 | 53 | 0.480 |
Why?
|
| Testosterone | 2 | 2021 | 70 | 0.470 |
Why?
|
| Androgen-Insensitivity Syndrome | 1 | 2013 | 4 | 0.440 |
Why?
|
| Pregnancy Complications, Neoplastic | 1 | 2013 | 6 | 0.440 |
Why?
|
| Clinical Competence | 2 | 2018 | 204 | 0.440 |
Why?
|
| Preoperative Care | 1 | 2013 | 76 | 0.430 |
Why?
|
| Faculty, Medical | 4 | 2020 | 51 | 0.410 |
Why?
|
| Pregnancy, Ectopic | 1 | 2012 | 11 | 0.400 |
Why?
|
| Watchful Waiting | 1 | 2012 | 18 | 0.400 |
Why?
|
| Young Adult | 6 | 2019 | 2581 | 0.360 |
Why?
|
| Career Choice | 3 | 2020 | 52 | 0.360 |
Why?
|
| Male | 10 | 2019 | 12870 | 0.360 |
Why?
|
| Insulin Resistance | 2 | 2021 | 165 | 0.340 |
Why?
|
| Adolescent | 4 | 2019 | 2957 | 0.340 |
Why?
|
| Retrospective Studies | 5 | 2021 | 2433 | 0.330 |
Why?
|
| Receptors, LHRH | 4 | 2021 | 17 | 0.330 |
Why?
|
| Prevalence | 3 | 2019 | 472 | 0.320 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2013 | 802 | 0.320 |
Why?
|
| Health Care Surveys | 2 | 2019 | 67 | 0.320 |
Why?
|
| Ovarian Reserve | 2 | 2019 | 9 | 0.290 |
Why?
|
| Ovarian Neoplasms | 1 | 2013 | 563 | 0.280 |
Why?
|
| Chorionic Gonadotropin | 3 | 2023 | 22 | 0.280 |
Why?
|
| Biomarkers | 1 | 2010 | 733 | 0.270 |
Why?
|
| Anti-Mullerian Hormone | 3 | 2019 | 6 | 0.270 |
Why?
|
| Autoantibodies | 4 | 2021 | 466 | 0.260 |
Why?
|
| African Americans | 2 | 2019 | 350 | 0.260 |
Why?
|
| Schools, Medical | 3 | 2022 | 45 | 0.250 |
Why?
|
| Estradiol | 3 | 2014 | 174 | 0.240 |
Why?
|
| Prospective Studies | 5 | 2019 | 1217 | 0.240 |
Why?
|
| Surveys and Questionnaires | 3 | 2019 | 918 | 0.230 |
Why?
|
| Ovarian Hyperstimulation Syndrome | 1 | 2023 | 1 | 0.220 |
Why?
|
| Fertilization | 1 | 2023 | 9 | 0.220 |
Why?
|
| Preconception Care | 1 | 2023 | 17 | 0.210 |
Why?
|
| Abortion, Habitual | 1 | 2002 | 4 | 0.210 |
Why?
|
| Burnout, Professional | 2 | 2019 | 19 | 0.200 |
Why?
|
| Sexism | 2 | 2019 | 6 | 0.200 |
Why?
|
| School Admission Criteria | 1 | 2020 | 6 | 0.180 |
Why?
|
| Mentors | 2 | 2018 | 31 | 0.180 |
Why?
|
| Internship and Residency | 2 | 2020 | 224 | 0.180 |
Why?
|
| Aging | 3 | 2014 | 945 | 0.180 |
Why?
|
| Educational Measurement | 2 | 2018 | 111 | 0.180 |
Why?
|
| Case-Control Studies | 2 | 2018 | 700 | 0.180 |
Why?
|
| Middle Aged | 6 | 2019 | 6818 | 0.170 |
Why?
|
| Treatment Outcome | 2 | 2018 | 2264 | 0.170 |
Why?
|
| Combined Modality Therapy | 2 | 2018 | 288 | 0.170 |
Why?
|
| Semen Analysis | 1 | 2019 | 9 | 0.170 |
Why?
|
| Sperm Motility | 1 | 2019 | 11 | 0.170 |
Why?
|
| Sperm Count | 1 | 2019 | 13 | 0.160 |
Why?
|
| Professional Misconduct | 1 | 2019 | 3 | 0.160 |
Why?
|
| Resilience, Psychological | 1 | 2019 | 18 | 0.160 |
Why?
|
| Health Services | 1 | 2019 | 12 | 0.160 |
Why?
|
| Cohort Studies | 1 | 2021 | 858 | 0.160 |
Why?
|
| Immunoassay | 1 | 2019 | 35 | 0.160 |
Why?
|
| Social Environment | 1 | 2019 | 56 | 0.160 |
Why?
|
| Simulation Training | 1 | 2018 | 19 | 0.160 |
Why?
|
| Education, Medical | 1 | 2019 | 61 | 0.160 |
Why?
|
| Employee Performance Appraisal | 1 | 2018 | 5 | 0.150 |
Why?
|
| Mental Health | 1 | 2019 | 96 | 0.150 |
Why?
|
| Hyperandrogenism | 1 | 2018 | 11 | 0.150 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2019 | 113 | 0.150 |
Why?
|
| Health Status | 1 | 2019 | 145 | 0.150 |
Why?
|
| Preceptorship | 1 | 2018 | 16 | 0.150 |
Why?
|
| Cross-Sectional Studies | 2 | 2019 | 910 | 0.150 |
Why?
|
| Asian Americans | 1 | 2018 | 40 | 0.150 |
Why?
|
| Lipids | 1 | 2019 | 195 | 0.150 |
Why?
|
| Observational Studies as Topic | 1 | 2018 | 53 | 0.150 |
Why?
|
| Amenorrhea | 1 | 2017 | 5 | 0.150 |
Why?
|
| Pelvic Pain | 1 | 2017 | 10 | 0.150 |
Why?
|
| Program Evaluation | 1 | 2018 | 162 | 0.140 |
Why?
|
| Vagina | 1 | 2017 | 42 | 0.140 |
Why?
|
| Quality of Life | 2 | 2019 | 464 | 0.130 |
Why?
|
| Phenotype | 1 | 2018 | 665 | 0.130 |
Why?
|
| Premenopause | 1 | 2015 | 20 | 0.130 |
Why?
|
| Life Style | 1 | 2015 | 83 | 0.120 |
Why?
|
| Obesity | 1 | 2021 | 650 | 0.120 |
Why?
|
| Electronic Health Records | 1 | 2015 | 59 | 0.120 |
Why?
|
| Birth Rate | 1 | 2014 | 11 | 0.120 |
Why?
|
| Inhibins | 2 | 2012 | 8 | 0.110 |
Why?
|
| Orchiectomy | 1 | 2013 | 12 | 0.110 |
Why?
|
| Epididymis | 1 | 2013 | 8 | 0.110 |
Why?
|
| Follicle Stimulating Hormone | 2 | 2012 | 71 | 0.110 |
Why?
|
| Osteoporosis | 1 | 2013 | 63 | 0.110 |
Why?
|
| Risk Factors | 1 | 2018 | 2011 | 0.100 |
Why?
|
| Adnexa Uteri | 1 | 2012 | 2 | 0.100 |
Why?
|
| Progesterone | 1 | 2013 | 128 | 0.100 |
Why?
|
| Fertility Preservation | 1 | 2012 | 6 | 0.100 |
Why?
|
| Gonadotropin-Releasing Hormone | 2 | 2023 | 37 | 0.100 |
Why?
|
| Counseling | 1 | 2012 | 52 | 0.100 |
Why?
|
| Practice Guidelines as Topic | 1 | 2013 | 233 | 0.100 |
Why?
|
| Reproduction | 1 | 2012 | 63 | 0.100 |
Why?
|
| Patient Selection | 1 | 2012 | 143 | 0.100 |
Why?
|
| Models, Biological | 1 | 2014 | 446 | 0.090 |
Why?
|
| Animals | 3 | 2021 | 9960 | 0.090 |
Why?
|
| Laparoscopy | 1 | 2012 | 143 | 0.090 |
Why?
|
| Oklahoma | 1 | 2013 | 973 | 0.090 |
Why?
|
| Blood Glucose | 2 | 2021 | 300 | 0.090 |
Why?
|
| Cytokines | 2 | 2021 | 438 | 0.080 |
Why?
|
| Reproducibility of Results | 1 | 2010 | 747 | 0.070 |
Why?
|
| Rats | 2 | 2021 | 1545 | 0.070 |
Why?
|
| Risk Assessment | 2 | 2023 | 587 | 0.070 |
Why?
|
| Delphi Technique | 1 | 2023 | 17 | 0.060 |
Why?
|
| Consensus | 1 | 2023 | 69 | 0.050 |
Why?
|
| Ovulation Induction | 1 | 2023 | 33 | 0.050 |
Why?
|
| Reference Values | 1 | 2002 | 198 | 0.050 |
Why?
|
| Fasting | 1 | 2002 | 77 | 0.050 |
Why?
|
| Women's Health | 1 | 2022 | 58 | 0.050 |
Why?
|
| Fluorescence Resonance Energy Transfer | 1 | 2021 | 18 | 0.050 |
Why?
|
| Follicular Atresia | 1 | 2021 | 4 | 0.050 |
Why?
|
| Biological Assay | 1 | 2021 | 34 | 0.050 |
Why?
|
| Glucose Transporter Type 2 | 1 | 2021 | 4 | 0.050 |
Why?
|
| Insulin Receptor Substrate Proteins | 1 | 2021 | 22 | 0.050 |
Why?
|
| Luteinizing Hormone | 1 | 2021 | 57 | 0.050 |
Why?
|
| Delivery of Health Care | 1 | 2022 | 111 | 0.050 |
Why?
|
| Epitopes | 1 | 2021 | 171 | 0.050 |
Why?
|
| Insulin | 1 | 2002 | 310 | 0.050 |
Why?
|
| Mentoring | 1 | 2020 | 10 | 0.050 |
Why?
|
| Professional Role | 1 | 2020 | 42 | 0.040 |
Why?
|
| Glucose Transporter Type 4 | 1 | 2021 | 62 | 0.040 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2021 | 130 | 0.040 |
Why?
|
| Endometrium | 1 | 2020 | 38 | 0.040 |
Why?
|
| Organizational Policy | 1 | 2019 | 19 | 0.040 |
Why?
|
| Bullying | 1 | 2019 | 5 | 0.040 |
Why?
|
| Peptides | 1 | 2021 | 280 | 0.040 |
Why?
|
| Shame | 1 | 2019 | 6 | 0.040 |
Why?
|
| Mindfulness | 1 | 2019 | 8 | 0.040 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2021 | 545 | 0.040 |
Why?
|
| Adipose Tissue | 1 | 2021 | 178 | 0.040 |
Why?
|
| Racism | 1 | 2019 | 11 | 0.040 |
Why?
|
| Sleep | 1 | 2019 | 100 | 0.040 |
Why?
|
| Education, Medical, Graduate | 1 | 2019 | 102 | 0.040 |
Why?
|
| Intergenerational Relations | 1 | 2017 | 11 | 0.040 |
Why?
|
| Computer-Assisted Instruction | 1 | 2017 | 27 | 0.040 |
Why?
|
| Learning | 1 | 2017 | 92 | 0.030 |
Why?
|
| Muscle, Skeletal | 1 | 2021 | 578 | 0.030 |
Why?
|
| Social Media | 1 | 2017 | 50 | 0.030 |
Why?
|
| Contraceptives, Oral | 1 | 2015 | 22 | 0.030 |
Why?
|
| Work Schedule Tolerance | 1 | 2015 | 10 | 0.030 |
Why?
|
| Learning Curve | 1 | 2015 | 13 | 0.030 |
Why?
|
| Task Performance and Analysis | 1 | 2015 | 37 | 0.030 |
Why?
|
| Workload | 1 | 2015 | 38 | 0.030 |
Why?
|
| Operating Rooms | 1 | 2015 | 17 | 0.030 |
Why?
|
| Interpersonal Relations | 1 | 2015 | 64 | 0.030 |
Why?
|
| Teaching | 1 | 2015 | 76 | 0.030 |
Why?
|
| Exercise | 1 | 2019 | 451 | 0.030 |
Why?
|
| Chi-Square Distribution | 1 | 2014 | 144 | 0.030 |
Why?
|
| Vitamins | 1 | 2013 | 22 | 0.030 |
Why?
|
| Bone Density Conservation Agents | 1 | 2013 | 18 | 0.030 |
Why?
|
| Analysis of Variance | 1 | 2014 | 388 | 0.030 |
Why?
|
| Alcohol Drinking | 1 | 2015 | 162 | 0.030 |
Why?
|
| Risk Reduction Behavior | 1 | 2013 | 40 | 0.030 |
Why?
|
| Congresses as Topic | 1 | 2012 | 32 | 0.020 |
Why?
|
| Menstrual Cycle | 1 | 2012 | 22 | 0.020 |
Why?
|
| Dietary Supplements | 1 | 2013 | 213 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2014 | 843 | 0.020 |
Why?
|
| Smoking | 1 | 2015 | 465 | 0.020 |
Why?
|
| Time Factors | 1 | 2014 | 1562 | 0.020 |
Why?
|